Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial.

By J. O'reardon, H. Solvason, P. Janicak, S. Sampson, K. Isenberg, Z. Nahas, William W. McDonald, D. Avery, P. Fitzgerald, C. Loo and 3 more. Biological Psychiatry, 2007

1,735 citations recorded by the source corpus.

Subfields: Anesthesiology and Pain Medicine, Cognitive Neuroscience, Neurology

View Paper: https://www.semanticscholar.org/paper/846b8457d2ca1fa8e05382bc8169fb7b25fea20a

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Anesthesiology and Pain Medicine

In Cognitive Neuroscience

In Neurology

Citations in the corpus

Electric field depth–focality tradeoff in transcranial magnetic stimulation: simulation comparison of 50 coil designs (2012, neutral): “On the other hand, the large S1/2 of H coils could also contribute to therapeutic effectiveness, with reported remission rate in depression [80] nearly twice that reported with the Neuronetics ferromagnetic core figure-8 coil (#34) [144], though stimulation parameters besides the coils differed in t”
Identification of reproducible individualized targets for treatment of depression with TMS based on intrinsic connectivity (2012, positive): “Its most common use involves high-frequency stimulation to the left dorsal lateral prefrontal cortex (DLPFC) for the treatment of depression (George et al., 1995; O'Reardon et al., 2007; Padberg and George, 2009; Pascual-Leone et al., 1996).”
Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic (2007, background): “Another recent, multisite review is promising in both treatment efficacy and tolerabilit”